熱門資訊> 正文

Iterum Therapeutics第三季度盈利预览

2025-11-13 23:46

Iterum Therapeutics plc(ITRM) 0

Iterum Therapeutics (ITRM) is scheduled to announce Q3 earnings results on Friday, November 14th, before market open.
The consensus EPS Estimate is -$0.09 (+62.5% Y/Y)Over the last 2 years, ITRM has beaten EPS estimates 25% of the time and has beaten revenue estimates 0% of the time.

More on Iterum Therapeutics

Seeking Alpha’s Quant Rating on Iterum Therapeutics
Historical earnings data for Iterum Therapeutics
Financial information for Iterum Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。